A Prospective, double blind, Mechanism of Action Trial Assessing the Effect of Nolasiban on Contractions, Blood Flow and Gene Expression in premenopausal women
Latest Information Update: 10 Aug 2021
Price :
$35 *
At a glance
- Drugs Nolasiban (Primary)
- Indications Female infertility; Preterm labour
- Focus Pharmacodynamics; Therapeutic Use
- 10 Aug 2021 New trial record
- 04 Aug 2021 According to an ObsEva media release, Piotr Pierzynski, M.D., Ph.D is investigator in the study.
- 04 Aug 2021 According to an ObsEva media release, results from this study published in the Journal of Reproductive BioMedicine Online.